BrightSpring Health Services (NASDAQ:BTSG) Sets New 12-Month High – Here’s Why

BrightSpring Health Services, Inc. (NASDAQ:BTSG)’s stock price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $32.34 and last traded at $32.25, with a volume of 14370783 shares changing hands. The stock had previously closed at $30.47.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on BTSG. Morgan Stanley boosted their price target on BrightSpring Health Services from $25.00 to $32.00 and gave the company an “overweight” rating in a report on Tuesday, October 14th. Mizuho boosted their price target on BrightSpring Health Services from $26.00 to $32.00 and gave the company an “outperform” rating in a report on Friday. Wall Street Zen downgraded BrightSpring Health Services from a “strong-buy” rating to a “buy” rating in a report on Saturday, July 26th. Bank of America lifted their price objective on BrightSpring Health Services from $27.50 to $31.00 and gave the company a “buy” rating in a research report on Wednesday, September 10th. Finally, UBS Group lifted their price objective on BrightSpring Health Services from $31.00 to $35.00 and gave the company a “buy” rating in a research report on Monday, October 13th. Ten investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $32.56.

BrightSpring Health Services Stock Performance

The company has a 50-day simple moving average of $26.66 and a two-hundred day simple moving average of $22.88. The company has a debt-to-equity ratio of 1.43, a quick ratio of 1.34 and a current ratio of 1.76. The firm has a market capitalization of $5.71 billion, a P/E ratio of 52.87, a PEG ratio of 0.46 and a beta of 2.40.

BrightSpring Health Services (NASDAQ:BTSG) last posted its quarterly earnings data on Monday, October 20th. The company reported $0.30 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.03. The business had revenue of $3.33 billion for the quarter, compared to analysts’ expectations of $3.16 billion. BrightSpring Health Services had a return on equity of 11.83% and a net margin of 1.04%. BrightSpring Health Services has set its Q3 2025 guidance at 0.300-0.300 EPS. FY 2025 guidance at EPS. As a group, equities analysts forecast that BrightSpring Health Services, Inc. will post 0.59 EPS for the current year.

Institutional Trading of BrightSpring Health Services

A number of hedge funds have recently made changes to their positions in BTSG. Highland Capital Management LLC bought a new stake in shares of BrightSpring Health Services in the 1st quarter worth approximately $181,000. Lisanti Capital Growth LLC boosted its position in shares of BrightSpring Health Services by 3.3% in the 1st quarter. Lisanti Capital Growth LLC now owns 343,015 shares of the company’s stock worth $6,205,000 after purchasing an additional 11,105 shares in the last quarter. Teacher Retirement System of Texas boosted its position in shares of BrightSpring Health Services by 6.8% in the 1st quarter. Teacher Retirement System of Texas now owns 14,650 shares of the company’s stock worth $265,000 after purchasing an additional 932 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of BrightSpring Health Services by 24.3% in the 1st quarter. Bank of New York Mellon Corp now owns 195,372 shares of the company’s stock worth $3,534,000 after purchasing an additional 38,159 shares in the last quarter. Finally, New York State Common Retirement Fund boosted its position in shares of BrightSpring Health Services by 131.8% in the 1st quarter. New York State Common Retirement Fund now owns 37,918 shares of the company’s stock worth $686,000 after purchasing an additional 21,563 shares in the last quarter.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.